$NXGL

NEXGEL, INC.

No enriched coverage for $NXGL in the last 7 days.

No SEC Form 4 filings for $NXGL in the last 30 days.

See all $NXGL insider activity →
Med

NEXGEL, INC. (NXGL): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

NEXGEL, INC. (NXGL) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Exhibit 99.1 NEXGEL ANNOUNCES LEADERSHIP TRANSITION AND STRATEGIC REVIEW INITIATIVE LANGHORNE, Pa. – August 20, 2026 – NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”) today announced a series of leadership, governance and strategic initiatives designed to strengthen ope

NEXGEL Reports Q2 2026 Results; Revenue Growth Offset By Net Loss; Stock Down

NEXGEL (NXGL) reported Q2 2026 revenue of $3.69M, up from $2.88M a year earlier, citing Celularity transaction growth and BioNX Surgical integration. The quarter showed a net loss of $2.87M, attributed to integration costs, intangible amortization, transaction expenses, and a SilverSeal inventory recall. Shares trade around $0.39, down 30% YTD.

NEXGEL, INC. (NXGL): Results of Operations and Financial Condition

NEXGEL, INC. (NXGL) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 NEXGEL Reports Second Quarter 2026 Financial Results LANGHORNE, Pa. – August 17, 2026 – NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content

NXGL sentiment & insider activity

Recent NXGL coverage spans corporate actions, insider activity and earnings.

What's driving NXGL

  • Leadership transition may cause short‑term volatility and affect execution of strategic initiatives.

    SEC EDGAR 8-K · Aug 21, 2026

  • Results show revenue growth but continued losses tied to integration and recall-related charges, likely keeping near-term sentiment pressured.

    rttnews.com · Aug 17, 2026

  • This is a results-of-operations 8-K, but the scraped body does not include the actual financial figures or guidance, limiting actionable signal.

    SEC EDGAR 8-K · Aug 17, 2026

  • The vote outcome reduces near-term likelihood of a Nevada reincorporation, share-authority expansion, and a reverse split, but confirms board continuity and approval for conversion/warrant-related issuance.

    SEC EDGAR 8-K · Aug 5, 2026

  • The filing is primarily governance and compensation detail, with limited direct implications for near-term fundamentals.

    SEC EDGAR 8-K · Jul 29, 2026

AlphAI scores every news story that mentions NXGL with an AI model for sentiment and relevance, and aggregates insider trades from NEXGEL, INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $NXGL

Score
$NXGLMed

NEXGEL, INC. (NXGL): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

NEXGEL, INC. (NXGL) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Exhibit 99.1 NEXGEL ANNOUNCES LEADERSHIP TRANSITION AND STRATEGIC REVIEW INITIATIVE LANGHORNE, Pa. – August 20, 2026 – NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”) today announced a series of leadership, governance and strategic initiatives designed to strengthen ope

$NXGLLow

NEXGEL, INC. (NXGL): Results of Operations and Financial Condition

NEXGEL, INC. (NXGL) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 NEXGEL Reports Second Quarter 2026 Financial Results LANGHORNE, Pa. – August 17, 2026 – NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content

NEXGEL, INC. (NXGL): Submission of Matters to a Vote of Security Holders

NEXGEL, INC. (NXGL) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. Item 5.07. Submission of Matters to a Vote of Security Holders. On July 31, 2026, NexGel, Inc. (the “ Company ”) held its 2026 Annual Meeting of Stockholders (the “ Annual Meeting ”). At the Annual Meeting, there were 6,398,925 shares of common stock represented in person or by p

$NXGLLow

NEXGEL, INC. (NXGL): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

NEXGEL, INC. (NXGL) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Levy Employment Agreement On July 23, 2026, NexGel, Inc. (the “ Company ”) entered into an Executive Employment Agreement w

NEXGEL, INC. (NXGL): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

NEXGEL, INC. (NXGL) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. false 0001468929 0001468929 2026-06-29 2026-06-29 0001468929 NXGL:CommonStockParValue0.001Member 2026-06-29 2026-06-29 0001468929 NXGL:WarrantsToPurchaseCommonStockMember 2026-06-29 2026-06-29 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE

Related tickers